1. Home
  2. DOMO vs XGN Comparison

DOMO vs XGN Comparison

Compare DOMO & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

N/A

Current Price

$3.84

Market Cap

132.7M

Sector

Technology

ML Signal

N/A

Logo Exagen Inc.

XGN

Exagen Inc.

N/A

Current Price

$7.84

Market Cap

110.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DOMO
XGN
Founded
2010
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.7M
110.7M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
DOMO
XGN
Price
$3.84
$7.84
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$10.28
$8.86
AVG Volume (30 Days)
1.2M
244.4K
Earning Date
05-20-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
N/A
EPS
N/A
N/A
Revenue
$318,857,000.00
N/A
Revenue This Year
$3.41
$8.12
Revenue Next Year
$4.72
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.84
$2.59
52 Week High
$18.49
$12.23

Technical Indicators

Market Signals
Indicator
DOMO
XGN
Relative Strength Index (RSI) 57.42 60.19
Support Level $3.32 $4.08
Resistance Level $4.05 $7.99
Average True Range (ATR) 0.15 0.40
MACD 0.00 -0.10
Stochastic Oscillator 75.31 58.29

Price Performance

Historical Comparison
DOMO
XGN

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: